Skip to main content

WELLS FARGO & COMPANY/MN

Position in ANIK — Anika Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in ANIK

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$69,281
-$71,745 QoQ
Shares Held
4,778
-67.4% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $924,834,436 across 59 Drug Manufacturers - Specialty & Generic names. ANIK ranks #43 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIK

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $69,281 4,778
2025-12-31 $141,026 14,675
2025-09-30 $95,973 10,210
2025-06-30 $96,817 9,151
2025-03-31 $122,238 8,133
2024-12-31 $122,148 7,421
2024-09-30 $139,851 5,662
2024-06-30 $154,689 6,107
2024-03-31 $131,469 5,176
2023-12-31 $102,264 4,513
2023-09-30 $76,792 4,122
2023-06-30 $293,260 11,288
2023-03-31 $239,926 8,354
2022-12-31 $19,772 668
2022-09-30 $33,295 1,399
2022-06-30 $39,662 1,777
2022-03-31 $401,733 15,999
2021-12-31 $723,800 20,201
2021-09-30 $1,479,725 34,768
2021-06-30 $1,370,561 31,660
2021-03-31 $399,944 9,805
2020-12-31 $8,865,074 195,870
2020-09-30 $6,833,064 193,079
2020-06-30 $7,504,081 198,889
2020-03-31 $6,882,486 238,066